Resultados y vida financieraSalud - Farma - Biotecnología
GUERBET : Update on discussions with financial partners.
02/11/2026 08:30
AMFPublicación inmediata
Villepinte, November 2, 2026, 8.30 A.m.: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, announces, further to its latest communications, that discussions with its financial partners are ongoing with a view to finalizing its refinancing.
Contacts:
Guerbet
Jérôme Estampes, Chief Financial Officer +33 (0)1 45915000 / jerome.estampes@guerbet.com
Christine Allard, SVP Public Affairs and Corporate Communications +33 6 30115782 / christine.allard@guerbet.com
Seitosei.Actifin
Marianne Py, Financial Communication +33 6 85527693 / marianne.py@seitosei-actifin.com
Jennifer Jullia, Press +33 6 02084549 / jennifer.jullia@seitosei-actifin.com
Update on discussions with financial partners
Villepinte, November 2, 2026, 8.30 A.m.: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, announces, further to its latest communications, that discussions with its financial partners are ongoing with a view to finalizing its refinancing.
The Group will keep the market informed during November of the outcome of the negotiations with its financial partners.
Next event:
2026 annual sales
February 4, 2027 after market close
About Guerbet
At Guerbet, we build lasting relationships so that we enable people to live better. That is our purpose. We are a global leader in medical imaging, offering a comprehensive range of pharmaceutical products, medical devices, and digital and AI solutions for diagnostic and interventional imaging. As pioneers in contrast products for 100 years, with 2,746 employees worldwide, we continuously innovate and devote 10% of our revenue to Research and Development in four centers in France and the United States. Guerbet (GBT) is listed in Compartment B of Euronext Paris and generated revenue of €786 million in 2025. For more information, please visit www.guerbet.com.
Forward-looking statements
Certain information contained in this press release is not historical data but constitutes forward-looking statements. These forward-looking statements are based on estimates, forecasts and assumptions including, without limitation, assumptions regarding the Group’s current and future strategy and the economic environment in which the Group operates. They involve known and unknown risks, uncertainties and other factors, which may result in a significant difference between the Group’s actual performance and results and those presented explicitly or implicitly in these forward-looking statements.
These forward-looking statements are only valid as of the date of this press release and the Group expressly disclaims any obligation or commitment to issue an update or revision of the forward-looking statements contained in this press release to reflect changes in the assumptions, events, conditions or circumstances on which such forward-looking statements are based. Forward-looking statements contained in this press release are for Contacts: